Cliff Asness's CATX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 27,998 shares of Perspective Therapeutics, Inc. (CATX) worth $95,473, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in CATX, representing a fresh investment thesis on this company. Largest addition occurred in Q2 2026, adding 1,282 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Perspective Therapeutics (CATX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Perspective Therapeutics (CATX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +1,282 | Add 4.80% | 27,998 | $3.41 |
| Q1 2026 | +26,716 | New Buy | 26,716 | $4.17 |
Cliff Asness's Perspective Therapeutics Investment FAQs
Cliff Asness first purchased Perspective Therapeutics, Inc. (CATX) in Q1 2026, acquiring 26,716 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Perspective Therapeutics, Inc. (CATX) for 2 quarters since Q1 2026.
Cliff Asness's largest addition to Perspective Therapeutics, Inc. (CATX) was in Q1 2026, adding 26,716 shares worth $111,406.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 27,998 shares of Perspective Therapeutics, Inc. (CATX), valued at approximately $95,473.
As of the Q2 2026 filing, Perspective Therapeutics, Inc. (CATX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Perspective Therapeutics, Inc. (CATX) was 27,998 shares, as reported at the end of Q2 2026.